Cannasouth Limited (NZSE:CBD) signed an agreement to acquire remaining 50% stake in Cannasouth Cultivation Limited from Aaron Craig on July 4, 2021. Under the terms of the consideration, Cannasouth will acquire the remaining 50% of the shares on issue in Cannasouth Cultivation which it does not already own, together with all of the shareholder loans made to Cannasouth Cultivation by the Craig Family interests. The transaction will be settled as follows: an upfront payment of NZD 2 million at closing, NZD 0.5 million payment each after 12 and 18 months of closing of transaction and issuance of new stock amounting to NZD 0.54 million. In a separate transaction, Cannasouth agreed to acquire remaining 40% of stake in Midwest Pharmaceutics NZ Limited from Greenmeadows Health Limited and Mark Balchin for NZD 1 million. The transaction is subject to capital raising of NZD 6 million by September 30, 2021.